|
Volumn 43, Issue 4, 2011, Pages 1020-1023
|
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ADULT;
ANXIETY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DIARRHEA;
DRUG BLOOD LEVEL;
FEMALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTERPERSONAL COMMUNICATION;
KIDNEY DYSFUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES;
NAUSEA AND VOMITING;
PERCEPTION;
PERIPHERAL EDEMA;
PRIORITY JOURNAL;
PSYCHOLOGIC GENERAL WELL BEING INDEX;
QUALITY OF LIFE;
SCROTUM DISORDER;
SIDE EFFECT;
SKIN ULCER;
STATE TRAIT ANXIETY INVENTORY;
SUSTAINED RELEASE FORMULATION;
TRANSPLANT EFFECT QUESTIONNAIRE MODIFIED;
WELLBEING;
ADULT;
AGED;
ANALYSIS OF VARIANCE;
ANXIETY;
DELAYED-ACTION PREPARATIONS;
DRUG ADMINISTRATION SCHEDULE;
DRUG MONITORING;
FEMALE;
GRAFT REJECTION;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ITALY;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
PERCEPTION;
PSYCHIATRIC STATUS RATING SCALES;
QUALITY OF LIFE;
QUESTIONNAIRES;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
TRUTH DISCLOSURE;
|
EID: 79957615466
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.03.048 Document Type: Conference Paper |
Times cited : (16)
|
References (13)
|